Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

March 1, 1987; Volume 28,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Fettich, J.

    1. You have access
      Quantitation of Iodine-123 MIBG Uptake by Normal Adrenal Medulla in Hypertensive Patients
      J. Bomanji, W. D. Flatman, T. Horne, J. Fettich, K. E. Britton, G. Ross and G. M. Besser
      Journal of Nuclear Medicine March 1, 1987, 28 (3) 319-324;
  2. Flatman, W. D.

    1. You have access
      Quantitation of Iodine-123 MIBG Uptake by Normal Adrenal Medulla in Hypertensive Patients
      J. Bomanji, W. D. Flatman, T. Horne, J. Fettich, K. E. Britton, G. Ross and G. M. Besser
      Journal of Nuclear Medicine March 1, 1987, 28 (3) 319-324;
  3. Fleming, John S.

    1. You have access
      Measurement of Glomerular Filtration Rate with Technetium-99m DTPA: Comparison of Plasma Clearance Techniques
      Derek G. Waller, Christopher M. Keast, John S. Fleming and Duncan M. Ackery
      Journal of Nuclear Medicine March 1, 1987, 28 (3) 372-377;
  4. Foon, Kenneth A.

    1. You have access
      Indium-111 T101 Monoclonal Antibody is Superior to Iodine-131 T101 in Imaging of Cutaneous T-Cell Lymphoma
      Jorge A. Carrasquillo, James L. Mulshine, Paul A. Bunn, James C. Reynolds, Kenneth A. Foon, Robert W. Schroff, Patricia Perentesis, Ronald G. Steis, Andrew M. Keenan, Mitchell Horowitz and Steven M. Larson
      Journal of Nuclear Medicine March 1, 1987, 28 (3) 281-287;
  5. Ford, Patrick V.

    1. You have access
      Utility of Total Body Gallium-67 Scintigraphy in a Patient with AIDS Related Complex
      Patrick V. Ford, Aileen B. Lim, Donald Abrams and Howard G. Parker
      Journal of Nuclear Medicine March 1, 1987, 28 (3) 402-404;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 28, Issue 3
March 1, 1987
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire